US2020297533A1PendingUtilityA1
Apparatus and method for treatment of dry eye using radio frequency heating
Est. expiryApr 8, 2036(~9.7 yrs left)· nominal 20-yr term from priority
A61B 18/14A61N 1/36046A61B 2018/00321A61N 1/36014A61F 9/0079
48
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure is related to a treatment probe and method for treating dry eye. The treatment probe may include a thin stainless steel tip, a spacer to ensure proper contact and protect the skin of a patient, a sensor to provide temperature feedback to the power supply providing RF energy to the treatment probe. The treatment focuses on a patient's temple and periorbital area.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A method of treatment for dry eye, the method comprising application of a radiofrequency energy to target tissue surrounding the eye in an amount sufficient to stimulate but not damage nerve tissue.
2 . A method according to claim 1 , wherein the radiofrequency energy is applied through a probe having at least one electrode surface that emits radiofrequency energy.
3 . A method according to claim 1 , wherein the radiofrequency energy applied to is low frequency.
4 . A method according to claim 1 , wherein the radiofrequency energy is emitted at a range of about 400 kHz to about 520 kHz; about 430 kHz to about 490 kHz; about 450 kHz to about 470 kHz; about 455 kHz to about 465 kHz; or about 460 kHz.
5 . A method according to claim 1 , wherein the radiofrequency energy is applied in an amount necessary to stimulate nerves to induce secretion of one or more Meibomian glands.
6 . A method according to claim 1 , wherein the radiofrequency energy is applied for a period of time and at a level necessary to raise the surface temperature of the target tissue to a temperature between 35 to 47 degrees Celsius.
7 . A method according to claim 6 , wherein the radiofrequency energy is applied for a period of time and at a frequency necessary to raise the surface temperature of the target tissue to a temperature between 38 to 45 degrees Celsius.
8 . A method according to claim 7 , wherein the radiofrequency energy is applied for a period of time and at a frequency necessary to raise the surface temperature of the target tissue to a temperature between 42 to 44 degrees Celsius.
9 . A method according to claim 1 , wherein the target tissue is heated at between 1 and 5 mm beneath the surface (i.e., between 2 and 2.5 mm beneath the surface).
10 . A method according to claim 9 , wherein the method further comprises applying an electrically conductive gel at the site of the target tissue on a patient.
11 . A method according to claim 1 , wherein the radiofrequency energy is applied to the temple and/or to periorbital tissue adjacent to the eye and/or eyelid.
12 . A method according to claim 11 , wherein the radiofrequency energy is applied to the temple and then is applied to the periorbital tissue adjacent to the eye and/or eyelid.
13 . A method according to claim 1 , wherein the radiofrequency energy is applied for a period of 15 seconds to 20 minutes, a period of 8 minutes to 15 minutes; a period of 8 minutes to 10 minutes; a period of 10 minutes to 12 minutes; or a period of 12 to 15 minutes.
14 . A method according to claim 1 , wherein the radiofrequency energy is not applied to the eyelid.
15 . A method according to claim 1 , further comprising contacting a grounding pad to a patient on an area of the skin removed from the tissue surrounding the eye.
16 . A method according to claim 1 , wherein the radiofrequency energy is applied using a probe that comprises:
a. an electrically conductive treatment tip positioned at the distal end of a handle, b. a cable in contact with the treatment tip and running from the distal end of the handle to the proximal end of the handle, the cable extending from the handle to a power supply providing radio-frequency energy to the tip through the cord, wherein the cord is removable from the power supply c. a spacer configured to provide an electrically conductive barrier between the treatment tip and a patient's skin, wherein the treatment tip is adapted to accept the spacer.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.